TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
BCYC

Bicycle Therapeutics Ltd

Healthcare · Biotechnology

3.70$ -1.6% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BCYC
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
95.4% 96.6% 94.0% 94.5% 96.6% 95.6% 90.0% 94.4% 97.0% 95.2%
79.4% 91.4% 77.6% 83.6% 84.4% 91.4% 82.6% 88.4% 91.9% 87.5%
79.4% 91.4% 77.6% 83.6% 84.4% 91.4% 82.6% 88.4% 91.9% 87.5%
11.6% 4.1% 13.9% 6.5% 9.1% 2.5% 5.2% 4.0% 3.7% 5.0%
0.0% 0.0% 0.0% 0.0% – – 0.0% – – –
4.4% 1.8% 2.2% 3.9% 2.2% 3.7% 8.0% – – –
0.0% 0.0% 0.0% – – – – – – –
0.0% 0.0% 0.0% – – – – – – –
32.2% 163.8% 185.5% 15.4% 40.8% 27.8% 34.1% 37.7% 17.1% 15.0%
32.2% 12.8% 10.9% 8.0% 14.4% 7.6% 13.0% 11.7% 7.0% 7.9%
0.0% 4.4% 0.0% 0.6% 0.5% 0.5% 0.8% 0.8% 0.6% 0.4%
15.9% 2.8% 2.3% 1.8% 0.8% 0.6% 1.6% 2.2% 1.7% 1.3%
0.0% 0.0% 0.0% – 9.0% 6.2% 7.4% 5.2% – –
67.8% -63.8% -85.5% 84.6% 59.2% 72.2% 65.9% 62.3% 82.9% 85.0%
-269.0% -65.0% -85.7% -91.2% -94.0% -45.5% -80.6% -86.0% -71.1% -125.4%
149.5% 18.0% 16.3% 10.0% 11.9% 5.2% 7.2% 6.0% 6.1% 9.7%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?